Oxybutynin 3.9mg/24hours transdermal patches was marked as discontinued in dm+d in August 2021. This means that once the September Gemscript update was installed, you could no longer prescribe it as an NHS prescription in Vision 3 or Vision Anywhere.
The item has since been re-instated in dm+d, however this will not be reflected in Vision 3 or Vision Anywhere until the December Gemscript update.
